Efalizumab for severe palmo-plantar psoriasis: An open-label pilot trial in five patients

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 4, 2009, Pages 415-419

  Brunasso, A M G ^a,b   Salvini, C ^c   Massone, C ^b  

^a GALLIERA HOSPITAL   (Italy)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Efalizumab; Palmo plantar psoriasis; PPPASI; Psoriasis

Indexed keywords

CYCLOSPORIN; EFALIZUMAB;

ADULT; AGED; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FEVER; HEADACHE; HEALTH CARE QUALITY; HUMAN; MALE; MYALGIA; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PAPULAR RASH; PILOT STUDY; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUSTULOSIS PALMOPLANTARIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CELL MIGRATION INHIBITION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSORIASIS;

EID: 62149150580     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03062.x     Document Type: Article

References (15)

1. Zangrilli A, Talamonti M, Saraceno R, Chimenti S. Clinical severity instruments. In Chimenti S, ed. Psoriasis. Societa' Editrice Italiana, Florence, Italy 2005 : 113 119.
2. Kumar B, Saraswat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 2002 82 : 192 195.
3. Marsland AM, Chalmers RJG, Hollis S, Leonardi-Bee J, Griffiths CE. Interventions for chronic palmoplantar pustulosis. Cochrane Database Sust Rev 2006 25 : 1 38.
4. Fretzin S, Crowley J, Jones L, Young M, Sobell J. Successful treatment of hand and foot psoriasis with efalizumab therapy. J Drugs Dermatol 2006 5 : 838 846.
5. Weinberg JM. Successful treatment of recalcitrant palmoplantar psoriasis with etanercept. Cutis 2003 72 : 396 398.
6. Prossick TA, Belsito D. Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis. Cutis 2006 78 : 178 180.
7. Myers W, Christiansen L, Gottlieb AB. Treatment of palmoplantar psoriasis with intramuscular alefacept. J Am Acad Dermatol 2005 53 : S127 S129.
8. Stinco G, Piccirillo F, Patrone P. Treatment of palmoplantar pustular psoriasis with efalizumab: a quick response with early recurrence. Eur J Dermatol 2008 18 : 91 92.
9. Wozel G, Vitez L. Palmoplantar Pustular Psoriasis: successful therapy with Efalizumab after Non-response to Infliximab. Acta Derm Venereol 2008 88 : 169 170.
10. Guenther LC. Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis. J Cutan Med Surg 2007 11 : 202 205.
11. Varma R, Cafardi JA, Cantrell W, Elmets C. Safety and efficacy of subcutaneously administered efalizumab in adults with moderate-to-severe hand and foot psoriasis: an open-label study. Am J Clin Dermatol 2008 9 : 105 109.
12. Leonardi CL, Sobell JM, Sofen H, Krell J. Phase IV study to evaluate the safety and efficacy of efalizumab for treatment of hand and foot psoriasis. J Am Acad Dermatol 2007 56 : AB48.
13. Kircik L. Treatment of hand and foot psoriasis with emphasis on efalizumab. Skin Ther Lett 2007 12 : 4 7.
14. Bhushan M, Burden AD, McElhone K, James R, Vanhoutte FP, Griffiths CE. Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2001 145 : 546 553.
15. Lowes MA, Chamian F, Abello MV et al. Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series. BMC Dermatol 2007 26 : 2.